The crimson papers are a series of short documents aimed at sharing knowledge regarding the process of scheduling plants, medicines, and substances within the international drug control treaty framework.
All the crimson papers (plus everything you need to know about Cannabis international scheduling …and what could change) is on this page: www.faaat.net/cannabis
The crimson papers
Pre- and Critical review: insights into the processes and procedures of the WHO scientific abuse liability assessment for drugs.
Full version of the paper in PDF
FAAAT Crimson paper #3 – The review(s).
RIBOULET ZEMOULI Kenzi
Barcelona, April 2018.
FAAAT think & do tank Editions
PARIS 75011, 8 RUE DU GÉNÉRAL RENAULT
The World Health Organization (WHO) is mandated by international law to review, assess and recommend appropriate levels of control to apply to each drug already included in the lists of the international Conventions, or susceptible to enter.
The process to come up with a public health benefit-risk assessment of drugs, plants, products, and substances liable to produce harms or addiction, is precisely defined by the rules and procedures of the WHO. Yet, it is complicated and leaves room for interpretation.
This paper aims to resume, explain and untangle the numerous doubts and uncertainties surrounding this process.
This paper briefly clarifies what the review process is, define its time frame and the documentation edited on this occasion, before exploring more in detail the different steps of the very reviews. The paper then synthesizes the methodology and scheduling criteria used by the ECDD, to conclude with a description of what happens after the assessments are over, once the ECDD emits scheduling recommendations to the United Nations system.